RESCRIPTOR 200 mg (Rescriptor 200 mg)
Generic Name: delavirdine
Pill imprint RESCRIPTOR 200 mg has been identified as Rescriptor 200 mg.
Rescriptor is used in the treatment of hiv infection and belongs to the drug class NNRTIs. Risk cannot be ruled out during pregnancy. Rescriptor 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
Rescriptor
- Generic Name:
- delavirdine
- Imprint:
- RESCRIPTOR 200 mg
- Strength:
- 200 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- NNRTIs
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- ViiV Healthcare
- National Drug Code (NDC):
- 49702-0210
- Inactive Ingredients:
- carnauba wax
silicon dioxide
croscarmellose sodium
lactose anhydrous
magnesium stearate
microcrystalline cellulose
hypromelloses
More about Rescriptor (delavirdine)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
